Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

EFNB1 – Craniofrontonasal Syndrome

Craniofrontonasal syndrome (CFNS) is a rare X-linked dominant disorder caused by pathogenic variants in EFNB1, characterized by frontonasal dysplasia, hypertelorism, coronal craniosynostosis, and a bifid nasal tip (PMID:15124102).

CFNS shows a paradoxical severity pattern in which heterozygous females exhibit multiple skeletal and craniofacial malformations, whereas hemizygous males often display only mild features such as hypertelorism (PMID:15959873). Segregation analysis in over 70 families demonstrates consistent co-segregation of EFNB1 variants with CFNS phenotypes.

To date, more than 140 unique loss-of-function alleles (nonsense, frameshift, splice) and over 30 distinct missense mutations in EFNB1 have been reported across familial and sporadic cases, including recurrent and de novo variants (PMID:15959873).

Functional studies confirm haploinsufficiency and cellular interference as key pathogenic mechanisms. Efnb1-null mice recapitulate CFNS skeletal defects, and patient-derived cell assays demonstrate impaired ephrin-B1 reverse signalling and mosaic cellular sorting (PMID:15124102; PMID:18043713; PMID:23335590).

Occasional reports of severely affected mosaic males further support the cellular interference model over simple dosage effects (PMID:23335590).

Overall, the EFNB1–CFNS association meets Definitive ClinGen criteria, with extensive genetic and experimental concordance. Key take-home: EFNB1 testing is essential for accurate diagnosis, genetic counseling, and management of CFNS.

References

  • American journal of human genetics • 2004 • Mutations of the ephrin-B1 gene cause craniofrontonasal syndrome PMID:15124102
  • Human Mutation • 2005 • Twenty-six novel EFNB1 mutations in familial and sporadic craniofrontonasal syndrome (CFNS) PMID:15959873
  • European journal of human genetics • 2008 • Dissecting the molecular mechanisms in craniofrontonasal syndrome: differential mRNA expression of mutant EFNB1 and the cellular mosaic PMID:18043713
  • Human molecular genetics • 2013 • Cellular interference in craniofrontonasal syndrome: males mosaic for mutations in the X-linked EFNB1 gene are more severely affected than true hemizygotes PMID:23335590

Evidence Based Scoring (AI generated)

Gene–Disease Association

Definitive

Numerous independent studies over >20 years with concordant phenotypes in heterozygous females, concordant mouse model, and broad mutation spectrum

Genetic Evidence

Strong

Over 200 probands documented with pathogenic EFNB1 variants across multiple cohorts (PMID:15124102; PMID:15959873)

Functional Evidence

Strong

Efnb1-null mice recapitulate CFNS features (PMID:15124102); cellular interference demonstrated in patient cells (PMID:18043713; PMID:23335590)